Usana Health Sciences (NYSE: USNA) revenue
Usana Health Sciences reported revenue of $925.3m for fiscal 2025, 8.3% more than in fiscal 2024 ($854.5m). Since fiscal 2016 its revenue has fallen by 8.0%, an average decline of 0.9% a year.
Usana Health Sciences's best year of the last 10 was fiscal 2018. The biggest drop was in fiscal 2022, −15.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $925.3m | +8.3% | $37.4m | 4.0% |
| 2024 | $854.5m | −7.2% | $66.3m | 7.8% |
| 2023 | $921.0m | −7.8% | $93.1m | 10.1% |
| 2022 | $998.6m | −15.8% | $107.6m | 10.8% |
| 2021 | $1,186m | +4.6% | $170.2m | 14.3% |
| 2020 | $1,135m | +7.0% | $176.5m | 15.6% |
| 2019 | $1,061m | −10.8% | $146.2m | 13.8% |
| 2018 | $1,189m | +13.6% | $188.4m | 15.8% |
| 2017 | $1,047m | +4.1% | $132.5m | 12.7% |
| 2016 | $1,006m | — | $138.6m | 13.8% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Usana Health Sciences revenue compared with its sector
By revenue for its latest fiscal year, Usana Health Sciences ranks 99th of the 119 US consumer staples companies with a page on Celsmar. The sector median grew 3.5% in its latest fiscal year; Usana Health Sciences, 8.3%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 97th | Grand Canyon Education | $1,106m | 7.1% |
| 98th | Freshpet | $1,102m | 13.0% |
| 99th | Usana Health Sciences | $925.3m | 8.3% |
| 100th | Perdoceo Education | $846.1m | 24.2% |
| 101st | Universal Technical Institute | $835.6m | 14.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US consumer staples stocks.
Questions about the revenue of Usana Health Sciences
- How much revenue did Usana Health Sciences make in fiscal 2025?
- Usana Health Sciences reported revenue of $925.3m for fiscal 2025, compared with $854.5m in fiscal 2024.
- How much has the revenue of Usana Health Sciences fallen?
- Between fiscal 2016 and fiscal 2025 it went from $1,006m to $925.3m: 8.0% less, an average decline of 0.9% a year.
- What was the best year for revenue at Usana Health Sciences?
- Of its last 10 fiscal years, fiscal 2018, with $1,189m.
- Where does Usana Health Sciences rank in its sector by revenue?
- It ranks 99th of the 119 US consumer staples companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Usana Health Sciences come from?
- From the annual report (Form 10-K) that Usana Health Sciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Usana Health Sciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Usana Health Sciences: the Usana Health Sciences page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.